Hiroaki Moriyama

2.8k total citations · 1 hit paper
67 papers, 2.2k citations indexed

About

Hiroaki Moriyama is a scholar working on Genetics, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hiroaki Moriyama has authored 67 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Genetics, 35 papers in Surgery and 29 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hiroaki Moriyama's work include Diabetes and associated disorders (45 papers), Pancreatic function and diabetes (35 papers) and Diabetes Management and Research (26 papers). Hiroaki Moriyama is often cited by papers focused on Diabetes and associated disorders (45 papers), Pancreatic function and diabetes (35 papers) and Diabetes Management and Research (26 papers). Hiroaki Moriyama collaborates with scholars based in Japan, United States and Canada. Hiroaki Moriyama's co-authors include George S. Eisenbarth, Dongmei Miao, Norio Abiru, Edwin Liu, Liping Yu, Maki Nakayama, Dale R. Wegmann, John C. Hutton, Koichi Yokono and Naru Babaya and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Hiroaki Moriyama

66 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice

2005 593 citations Maki Nakayama, Norio Abiru et al. Nature profile →

Peers

Hiroaki Moriyama

GENET

SURGE

IMMUN

EDM

Hannah A. DeBerg United States

Thomas Loudovaris Australia

Naomasa Yamamoto Japan

Rebecca Ashfield United Kingdom

Hongzhi Chen China

Akira Shimizu United States

R. L. Sutherland Australia

Takenori Kotani Japan

Cuihua Gao United States

Shun‐ichi Kurata Japan

Hannah A. DeBerg United States

Hiroaki Moriyama

322 ×0.2

GENET

239 ×0.2

SURGE

504 ×0.6

IMMUN

145 ×0.2

EDM

477 ×1.8

Citations per year, relative to Hiroaki Moriyama Hiroaki Moriyama (= 1×) peers Hannah A. DeBerg

Countries citing papers authored by Hiroaki Moriyama

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Moriyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Moriyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Moriyama more than expected).

Fields of papers citing papers by Hiroaki Moriyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Moriyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Moriyama. The network helps show where Hiroaki Moriyama may publish in the future.

Co-authorship network of co-authors of Hiroaki Moriyama

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Moriyama. A scholar is included among the top collaborators of Hiroaki Moriyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Moriyama. Hiroaki Moriyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yasuda, Hisafumi, Masaharu Nagata, Hiroaki Moriyama, et al.. (2011). Development of fulminant Type 1 diabetes with thrombocytopenia after influenza vaccination: a case report. Diabetic Medicine. 29(1). 88–89. 19 indexed citations

Yasuda, Hisafumi, Hiroaki Moriyama, Akira Nakamura, et al.. (2011). Acceleration of autoimmune diabetes in Rheb-congenic NOD mice with β-cell-specific mTORC1 activation. Biochemical and Biophysical Research Communications. 408(2). 306–311. 1 indexed citations

Arai, Takashi, Hiroaki Moriyama, Hisafumi Yasuda, et al.. (2010). Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice. Clinical Immunology. 136(1). 74–82. 6 indexed citations

Moriyama, Hiroaki, Takashi Arai, Hisafumi Yasuda, et al.. (2008). Autoreactive T Cell Response in CD25‐Negative Fraction of Peripheral Blood Mononuclear Cells in Established Type 1 Diabetes. Annals of the New York Academy of Sciences. 1150(1). 278–281. 3 indexed citations

Moriyama, Hiroaki, Takashi Arai, Hisafumi Yasuda, et al.. (2008). Intravenous Administration of Proinsulin 1 or 2–Expressing Fiber‐Mutant Recombinant Adenovirus Vector Protects against the Development of Diabetes in NOD Mice. Annals of the New York Academy of Sciences. 1150(1). 183–186. 4 indexed citations

Yasuda, Hisafumi, Maki Nakayama, Takashi Arai, et al.. (2008). NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes. Diabetes Research and Clinical Practice. 83(2). 200–207. 13 indexed citations

Nagata, Masao, et al.. (2007). Immunological aspects of ‘fulminant type 1 diabetes’. Diabetes Research and Clinical Practice. 77(3). S99–S103. 10 indexed citations

Babaya, Naru, Maki Nakayama, Hiroaki Moriyama, et al.. (2006). A new model of insulin-deficient diabetes: male NOD mice with a single copy of Ins1 and no Ins2. Diabetologia. 49(6). 1222–1228. 32 indexed citations

Nakayama, Maki, Norio Abiru, Hiroaki Moriyama, et al.. (2005). Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature. 435(7039). 220–223. 593 indexed citations breakdown →

10.

Devendra, Devasenan, et al.. (2004). Differential immune response to B:9-23 insulin 1 and insulin 2 peptides in animal models of type 1 diabetes. Journal of Autoimmunity. 23(1). 17–26. 17 indexed citations

11.

Devendra, Devasenan, Johanna Paronen, Edwin Liu, et al.. (2004). Differential Immune Induction with Subcutaneous versus Oral Administration of a Diabetogenic Insulin Peptide in the NOD Mouse. Annals of the New York Academy of Sciences. 1029(1). 328–330. 2 indexed citations

12.

Devendra, Devasenan, Johanna Paronen, Edwin Liu, et al.. (2004). Comparative study of Oral versus Subcutaneous B:9–23 insulin peptide in Balb/c mice as an experimental model for Autoimmune Diabetes. Annals of the New York Academy of Sciences. 1029(1). 331–333. 3 indexed citations

13.

Nakayama, Maki, Hiroaki Moriyama, Norio Abiru, et al.. (2004). Establishment of Native Insulin‐Negative NOD Mice and the Methodology to Distinguish Specific Insulin Knockout Genotypes and a B:16 Alanine Preproinsulin Transgene. Annals of the New York Academy of Sciences. 1037(1). 193–198. 10 indexed citations

14.

Liu, Edwin, Hiroaki Moriyama, Johanna Paronen, et al.. (2003). Nondepleting anti-CD4 monoclonal antibody prevents diabetes and blocks induction of insulin autoantibodies following insulin peptide B:9-23 immunization in the NOD mouse. Journal of Autoimmunity. 21(3). 213–219. 17 indexed citations

15.

Moriyama, Hiroaki, Takashi Ukai, & Yoshitaka Hara. (2002). Interferon-gamma Production Changes in Parallel with Bacterial Lipopolysaccharide Induced Bone Resorption in Mice: An Immunohistometrical Study. Calcified Tissue International. 71(1). 53–58. 15 indexed citations

16.

Liu, Edwin, Norio Abiru, Hiroaki Moriyama, Dongmei Miao, & George S. Eisenbarth. (2002). Induction of Insulin Autoantibodies and Protection from Diabetes with Subcutaneous Insulin B: 9‐23 Peptide without Adjuvant. Annals of the New York Academy of Sciences. 958(1). 224–227. 25 indexed citations

17.

Yasuda, Hisafumi, Michio Nagata, Ryotaro Yoshida, et al.. (1998). Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice.. Journal of Clinical Investigation. 102(10). 1807–1814. 50 indexed citations

18.

Nagata, Masao, Hisafumi Yasuda, Naoko Okamoto, et al.. (1998). Administration of IL-4 Prevents Autoimmune Diabetes but Enhances Pancreatic Insulitis in NOD Mice. Clinical Immunology and Immunopathology. 86(2). 209–218. 50 indexed citations

19.

Yokono, Koichi, Michio Nagata, Yohei Tominaga, et al.. (1997). CD8 cytotoxic T-cell clone rapidly transfers autoimmune diabetes in very young NOD and MHC class I-compatible scid mice. Diabetologia. 40(9). 1044–1052. 20 indexed citations

20.

Yokono, Koichi, Kazuhiko Amano, Masao Nagata, et al.. (1995). Administration of Monoclonal Antibodies against Vascular Cell Adhesion Molecule-1/Very Late Antigen-4 Abrogates Predisposing Autoimmune Diabetes in NOD Mice. Cellular Immunology. 165(2). 193–201. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact